#1 Clinical Trials Search in Europe

Norfloxacin

Norfloxacin is an antibiotic that has been studied in several clinical trials for its potential benefits in treating and preventing complications related to liver disease, particularly in patients with cirrhosis. This article summarizes key findings from clinical trials investigating the use of norfloxacin in conditions such as spontaneous bacterial peritonitis (SBP) and hepatopulmonary syndrome.

Table of Contents

What is Norfloxacin?

Norfloxacin is an antibiotic medication that belongs to a class of drugs called fluoroquinolones. It is used to treat various bacterial infections in the body. Norfloxacin is also known by the brand name Epinor[1].

What is Norfloxacin Used For?

Norfloxacin is prescribed to treat several types of infections caused by bacteria, including:

  • Urinary tract infections – Norfloxacin is commonly used to treat uncomplicated urinary tract infections (UTIs)[2].
  • Prostatitis – It can be used to treat prostate infections in men[2].
  • Gonorrhea – Norfloxacin is effective against the bacteria that cause gonorrhea[2].
  • Spontaneous bacterial peritonitis (SBP) – This is an infection of the abdominal cavity that can occur in patients with liver cirrhosis and ascites (fluid buildup in the abdomen). Norfloxacin is used to prevent recurrence of SBP in these patients[3].
  • Acute cystitis – Norfloxacin can be used to treat acute bladder infections[4].

How Does Norfloxacin Work?

Norfloxacin works by interfering with the bacteria’s ability to replicate its DNA. Specifically, it inhibits an enzyme called DNA gyrase, which is essential for bacterial DNA replication. By disrupting this process, Norfloxacin prevents the bacteria from growing and multiplying, ultimately leading to their death[5].

Dosage and Administration

The dosage of Norfloxacin can vary depending on the type and severity of the infection being treated. Some common dosages include:

  • For urinary tract infections: 400 mg twice daily for 3-7 days[6].
  • For prevention of spontaneous bacterial peritonitis: 400 mg once daily[3].
  • For acute cystitis: 400 mg twice daily for 3 days (for women aged 18-59)[4].

It’s important to take Norfloxacin exactly as prescribed by your doctor. The medication should be taken with a full glass of water, and you should drink plenty of fluids while on this treatment.

Potential Side Effects

Like all medications, Norfloxacin can cause side effects. Common side effects may include:

  • Nausea or upset stomach
  • Diarrhea
  • Headache
  • Dizziness

More serious side effects, though rare, can occur. These may include tendon problems, nerve damage, and changes in blood sugar levels. If you experience any unusual or severe side effects, contact your healthcare provider immediately[2].

Precautions and Warnings

Before taking Norfloxacin, inform your doctor if you:

  • Are allergic to any antibiotics
  • Have a history of tendon problems
  • Have kidney or liver disease
  • Are pregnant or breastfeeding
  • Have a history of seizures

Norfloxacin may interact with certain medications, so be sure to tell your doctor about all the medicines you are taking, including over-the-counter drugs and supplements[2].

Ongoing Research

Researchers continue to study Norfloxacin for various uses. Some ongoing areas of investigation include:

  • Comparison with other antibiotics: Studies are comparing the effectiveness of Norfloxacin with other antibiotics like Cephalosporin for treating acute cystitis[4].
  • Use in liver disease: Research is exploring the use of Norfloxacin in patients with liver cirrhosis to prevent complications like spontaneous bacterial peritonitis[3].
  • Combination therapies: Some studies are investigating the use of Norfloxacin in combination with other treatments, such as probiotics, for preventing infections in patients with liver disease[7].

In conclusion, Norfloxacin is a versatile antibiotic used to treat various bacterial infections. While it can be effective, it’s important to use it only as prescribed and to be aware of potential side effects and precautions. Always consult with your healthcare provider for personalized medical advice.

Aspect Details
Primary Use Prevention of spontaneous bacterial peritonitis (SBP) in cirrhosis patients
Common Dosage 400 mg orally once daily
Comparison Treatments Rifaximin, ciprofloxacin, placebo
Patient Population Cirrhosis patients with ascites, particularly those at high risk for SBP
Secondary Benefits Potential reduction in hepatorenal syndrome, improved survival in some studies
Areas of Investigation Hepatopulmonary syndrome, long-term prophylaxis efficacy
Concerns Potential for bacterial resistance with long-term use

FAQ

  • What is norfloxacin used for in liver disease? Norfloxacin is primarily studied for preventing spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites. It's also been investigated for other complications like hepatopulmonary syndrome.
  • How does norfloxacin compare to other treatments for SBP prevention? Clinical trials have compared norfloxacin to other antibiotics like rifaximin and ciprofloxacin, as well as to placebo. Results vary, but norfloxacin has shown effectiveness in preventing SBP in high-risk patients.
  • What is the typical dose of norfloxacin used in these studies? The most common dose used in clinical trials for SBP prevention is 400 mg of norfloxacin taken orally once daily.
  • Are there any side effects or risks associated with long-term norfloxacin use? While specific side effects weren't detailed in the trial summaries, long-term antibiotic use can lead to concerns about bacterial resistance. Some studies are exploring alternative treatments to address this issue.
  • Can norfloxacin improve survival in patients with severe liver disease? Some studies have investigated whether norfloxacin can improve survival in patients with advanced cirrhosis. One trial aimed to reduce 6-month mortality from 40% to 25% with norfloxacin treatment, but final results were not provided in the summary.

Ongoing Clinical Trials on Norfloxacin

  • Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

    Recruiting

    1 1
    Investigated drugs:
    Austria

  • Study Comparing Norfloxacin and Conventional Antibiotics for Hospitalized Patients with Decompensated Cirrhosis and Bacterial Infections

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Spontaneous Bacterial Peritonitis (SBP): A serious infection of the fluid in the abdominal cavity (ascites) that occurs in patients with advanced liver disease, particularly cirrhosis.
  • Cirrhosis: A late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism.
  • Ascites: The buildup of fluid in the abdominal cavity, often occurring as a complication of liver cirrhosis.
  • Hepatopulmonary Syndrome: A condition that affects some people with chronic liver disease where blood vessels in the lungs expand, leading to poor oxygenation.
  • Child-Pugh Score: A system used to assess the prognosis of chronic liver disease, mainly cirrhosis. It classifies severity as A (least severe), B (moderately severe), or C (most severe).
  • MELD Score: Model for End-Stage Liver Disease score, a numerical scale used for liver transplant prioritization.
  • Hepatorenal Syndrome: A type of kidney failure that occurs in patients with advanced liver disease, particularly those with cirrhosis.
  • Selective Intestinal Decontamination: The use of antibiotics to reduce the number of harmful bacteria in the intestines while preserving beneficial bacteria.

References

  1. https://clinicaltrials.gov/study/NCT02120196
  2. https://clinicaltrials.gov/study/NCT00362752
  3. https://clinicaltrials.gov/study/NCT04161768
  4. https://clinicaltrials.gov/study/NCT01527019
  5. https://clinicaltrials.gov/study/NCT01134692
  6. https://clinicaltrials.gov/study/NCT01542801
  7. https://clinicaltrials.gov/study/NCT00947336